27 Importantly, GLP-1 action is short-lived, with a half-life of just 12 minutes in the bloodstream under normal physiological conditions, after which it is broken down by the enzyme dipeptidyl peptidase IV (DPP-4), resulting in a loss of its biological activity
It plays an important role in detoxification
(source: prnewswire.com) GLP-1 Analogues Market Segmentation By Route of Administration Outlook Subcutaneous Route Oral Route By Product Outlook Ozempic Trulicity Mounjaro Wegovy Rybelsus Saxenda Victoza Zepbound Other Products By Application Outlook Type 2 Diabetes Mellitus Obesity Others Applications By Distribution Channel Outlook Hospital Pharmacies Retail Pharmacies Online Pharmacies By Regional Outlook North America US Canada Europe Germany France UK Italy Spain Netherlands Russia Rest of Europe Asia Pacific China Japan India Malaysia South Korea Indonesia Australia Vietnam Rest of Asia Pacific Middle East & Africa Saudi Arabia UAE Israel South Africa Rest of Middle East & Africa Latin America Mexico Brazil Argentina Rest of Latin America GLP-1 Analogues Market Report Scope Source: Polaris Market Research Analysis GLP-1 Analogues Market FAQ's The global GLP-1 analogues market size was valued at USD 56.62 billion in 2025

Rivaroxaban, Clopidogrel, and Ticagrelor Much like Apixaban, these three medications also common blood thinners, though less common than the above drugs have no known interactions with semaglutide, directly or indirectly
Please note: Health Coaches are not doctors and cannot prescribe, provide specific medical advice or diagnose you with any medical conditions
2001 May 22;56(10):14059